文献速递膀胱癌与上尿路尿路上皮癌小儿泌尿与泌尿修复

儿童与年轻成人尿路上皮癌的临床特征、复发与生存:一项系统综述

Clinical Characteristics, Recurrence, and Survival for Children and Young Adults With Urothelial Cancer: A Systematic Review.
PubMed 文献 · Urology · 2025-12-05

该系统综述纳入118篇文献共256例21岁及以下尿路上皮癌患者,中位诊断年龄13岁,男性占2:1。76%为低恶性潜能乳头状尿路上皮肿瘤或低级别尿路上皮癌,84%为非肌层浸润性疾病,局限性疾病患者复发率9%,中位复发时间12个月。作者认为该人群预后极佳但仍有约10%复发,建议长期随访并提出了基于风险的监测方案。

要点

  • 儿童及年轻成人尿路上皮癌多见于男性,中位诊断年龄13岁,多数表现为肉眼血尿。
  • 多数肿瘤为低级别、非肌层浸润性,但局限性疾病患者仍有9%复发,中位复发时间12个月。
  • 作者建议长期随访,并提出平衡监测负担与复发/进展风险的基于风险方案。

核心结论

  • 儿童与年轻成人尿路上皮癌患者预后极佳,但高达10%可复发,建议长期随访。

研究设计与样本

  • 系统综述,检索Medline截至2023年7月的同行评议报告,纳入21岁及以下儿童与年轻成人尿路上皮癌患者,共256例来自118篇文献。

主要发现

  • 男性占2:1,中位诊断年龄13岁(IQR 10-16)。
  • 3.1%患者有已知遗传综合征,78.5%表现为肉眼血尿。
  • 76%为低恶性潜能乳头状尿路上皮肿瘤或低级别尿路上皮癌,9%为高级别尿路上皮癌。
  • 84%为非肌层浸润性疾病,5.1%为肌层浸润性疾病。
  • 局限性疾病患者中9%出现肿瘤复发,初始切除后中位复发时间12个月(IQR 6-21),中位随访36个月(IQR 12-69)。

临床怎么用

  • 对儿童及年轻成人尿路上皮癌患者应进行长期随访,关注复发风险。
  • 可参考作者提出的基于风险的监测方案,权衡监测的患病率与费用及复发/进展风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To perform a systematic review of available data among children and young adults and propose a risk-based surveillance protocol. It was hypothesized that this population had favorable outcomes, with low rates of recurrence and death. METHODS: Medline was searched for peer-reviewed reports of pediatric and young adult (aged 21 years or below) urothelial cancer through July 2023. Demographic, clinical, and oncologic variables were extracted, with clinicopathological outcomes and survival described. RESULTS: Overall, 256 patients from 118 papers were included. There was a 2:1 male predominance, and the median age at diagnosis was 13 (IQR 10-16) years. 3.1% of patients had a known genetic syndrome and 78.5% presented with gross hematuria. 76% of patients had either papillary urothelial neoplasm of low malignant potential or low-grade urothelial carcinoma (UC), while 9% had high-grade UC. Regarding staging, 84% had non-muscle invasive and 5.1% had muscle invasive disease. Tumor recurrence was seen in 9% of patients with localized disease at presentation. Median time to recurrence after initial resection was 12 (IQR 6-21) months. The patients were followed for a median of 36 months (IQR 12-69). CONCLUSION: Children and young adult urothelial cancer patients have an excellent prognosis, but up to 10% can recur. The authors recommend long-term follow-up for these patients and herein suggest a risk-based protocol that balances the morbidity and costs of surveillance with the risk of recurrence and/or progression.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Aponte-Colon DA, Wilcox Vanden Berg R, Tua-Caraccia R, et al. Clinical Characteristics, Recurrence, and Survival for Children and Young Adults With Urothelial Cancer: A Systematic Review. Urology. 2025. PMID: 41354277. doi:10.1016/j.urology.2025.11.242

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。